Case number 2020-1598
Takeda Pharmaceutical Company v. Torrent Pharmaceuticals Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 16, 2021 | 14 | OPINION filed for the court by Dyk, Circuit Judge; Mayer, Circuit Judge and Chen, Circuit Judge. Nonprecedential Opinion. [756133] [20-1552, 20-1598] [JCP] [Entered: 02/16/2021 09:52 AM] (8) |
| Feb 16, 2021 | 15 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [756134] [20-1552, 20-1598] [JCP] [Entered: 02/16/2021 09:54 AM] (2) |
| Apr 22, 2020 | 13 | Docketing Statement for the Appellant Indoco Remedies Ltd.. Service: 04/22/2020 by email. [689329] [20-1598] [Ivan Poullaos] [Entered: 04/22/2020 06:35 PM] (4) |
| Apr 6, 2020 | 9 | **TEXT ONLY** ORDER granting motion to extend time to file other [7] filed by Appellant Indoco Remedies Ltd. The Entry of Appearance, Docketing Statement, and Certificate of Interest are due on or before 04/22/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [684207] [LMN] [Entered: 04/06/2020 08:31 AM] (0) |
| Apr 6, 2020 | 10 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: motion to extend time to file other Docket No. [7], ERROR: Appellant's motion did not include a certificate of compliance. CORRECTION: Pursuant to FRAP 32(g)(1), motions must contain a certificate of compliance with the word count. Please ensure future motions include the certificate of compliance. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [684208] [LMN] [Entered: 04/06/2020 08:33 AM] (0) |
| Apr 6, 2020 | 11 | ORDER consolidating appeals 20-1552 with 20-1598. The opening brief of both appellants is due no later than May 26, 2020. Service as of this date by the Clerk of Court. [684340] [20-1552, 20-1598] [LMN] [Entered: 04/06/2020 11:22 AM] (2) |
| Apr 6, 2020 | 12 | Note to file: The following cases are associated: 20-1552 Lead with 20-1598 Cross-Appeal. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [684342] [20-1552, 20-1598] [LMN] [Entered: 04/06/2020 11:24 AM] (0) |
| Apr 2, 2020 | 8 | REMINDER: Attorney Winchester is reminded that the information on the Entry of Appearance (EOA) and the information in the user account must match. Please promptly update the EOA or the account information on www.pacer.gov. [683636] [LMN] [Entered: 04/02/2020 08:52 AM] (0) |
| Apr 1, 2020 | 7 | MOTION of Appellant Indoco Remedies Ltd. Motion to Extend Deadline for Entry of Appearance, Certificate of Interest, and Docketing Statement [Consent: unopposed]. Service: 04/01/2020 by email. [683451] [20-1598] --[Edited 04/03/2020 by CAB to add correct relief] [Jamaica Szeliga] [Entered: 04/01/2020 01:23 PM] (6) |
| Mar 31, 2020 | 2 | Entry of appearance for Gregory A. Castanias as principal counsel for Appellees Takeda Ireland Limited, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Service: 03/31/2020 by email. [683279] [20-1598] [Gregory Castanias] [Entered: 03/31/2020 08:27 PM] (1) |
| Mar 31, 2020 | 3 | Entry of appearance for Lisamarie LoGiudice as of counsel for Appellees Takeda Ireland Limited, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Service: 03/31/2020 by email. [683280] [20-1598] [Gregory Castanias] [Entered: 03/31/2020 08:29 PM] (1) |
| Mar 31, 2020 | 4 | Entry of appearance for Jason G. Winchester as of counsel for Appellees Takeda Ireland Limited, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Service: 03/31/2020 by email. [683281] [20-1598] [Gregory Castanias] [Entered: 03/31/2020 08:30 PM] (1) |
| Mar 31, 2020 | 5 | Docketing Statement for the Appellees Takeda Ireland Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc. and Takeda Pharmaceutical Company Ltd.. Service: 03/31/2020 by email. [683282] [20-1598] [Gregory Castanias] [Entered: 03/31/2020 08:36 PM] (3) |
| Mar 31, 2020 | 6 | Certificate of Interest for Appellees Takeda Ireland Limited, Takeda Pharmaceutical Company Ltd., Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Service: 03/31/2020 by email. [683283] [20-1598] [Gregory Castanias] [Entered: 03/31/2020 08:38 PM] (2) |
| Mar 25, 2020 | 1 | Appeal docketed. Received: 03/16/2020. [681568]Entry of Appearance is due 04/08/2020. Certificate of Interest is due on 04/08/2020. Docketing Statement is due 04/08/2020. Appellant's brief is due 05/26/2020. [LMN] [Entered: 03/25/2020 09:33 AM] (94) |
